Anaplastic lymphoma kinase is an enzyme that is active during the embryonic nervous system development of humans, but slowly loses its activity over the course of postnatal life 1 . This enzyme is prone to various kinds of mutations notably chromosomal fusion. There are twenty such fusion proteins documented that are known to be involved predominantly in the pathogenesis of neuroblastoma, anaplastic large cell lymphomas and non-small cell lung cancer 2 . The fusion proteins of the produced from the mutated anaplastic lymphoma kinase gene dimerize to activate the catalytic site of the ALK protein kinase domain, which leads to the activation of multiple cell proliferation pathways like Ras/ Raf/MEK/ERK1/2 and the cell survival pathways like the JAK/STAT pathways 3 . ALK was originally identified as an fusion oncogene nucleophosmin (NPM)-ALK resulting from a t (2,5) chromosomal translocation in ALCL .The fusion oncogene NPM-ALK is implicated in the pathogenesis of ALCL as it is detected in approximately 75% of all ALK-positive ALCL (6) . Other ALK fusion genes, echinoderm microtubuleassociated protein like 4 (EML4)-ALK is proven to be associated with non-small cell lung cancer (NSCLC) 4 . A number of ATP-competitive ALK inhibitors have been developed and have proven oncolytic activity against ALK positive cancer cells both in vitro and in vivo. Biologicals like Crizotinib, developed as an ALK inhibitor have gained FDA approval for ALK positive cancer in EML4-ALK positive NSCLC and ALCL 4 . Few of these ALK inhibitors like Crizotinib (12) have advanced to the level of clinical trials 5, 6 ; Crizotinib recently gained FDA approval for ALK-positive cancers. It is used in the treatment of EML4-ALK-positive NSCLC but unfortunately like any other drugs it is also known to cause side effects. Hence, there is a need for the development of more potent and specific ALK inhibitors to reduce the adverse effects of the current drugs. In recent years, a number of ALK antagonists have appeared of which a set of novel and potent tetracyclic derivatives (6, 6-Dimethyl-11-oxo-6, 11-dihydro-5-H-benzo (b) carbazoles) (13) (14) (15) have been chosen for our present studies 7 . Vitex negundo, a plant native to South and Southeast Asia, is an erect shrub or small tree growing from 2 to 8 m (6.6 to 26.2 ft) in height. Vitex is a genus of flowering plants from the family Lamiaceae. It has about 250 species 8 . Species of Vitex are native throughout the tropics and subtropics and a few temperate regions 9 . Almost all parts of this plant has immense medicinal value, ranging from antimicrobial, anti-cancer, anti-inflammatory, anti-ulcer activity etc. It is one of the tropical plants with immense medicinal properties 10 .
METHODOLOGY
The molecular docking software used is this study is molegro virtual software.
Lead Identification & optimization
A comprehensive search of all possible studies on Vitex negundo compounds was made by searching the electronic literature (PubMed database) for relevant published reports and by manual searching of reference lists of articles on this topic. A total of 16 ligands with antineoplastic attribute were selected based on electronic literature study of the compounds present in Vitex negando plant (Pub med database). The structures of these ligands were downloaded from the pubchem database 11 .
ADMET Prediction
Once the compounds were selected, elementary physical descriptors like number of hydrogen bond acceptors and donors, log P, molecular weight were calculated for the selected compounds using molinspiration. Using these parameters the compounds were then scanned for "Lipinski's rile of 5". The shortlisted compounds that follow "Lipinskis rule of 5" were then chosen for further study and analysis 11 .
Target Identification
Structure of G1269A Mutant Anaplastic Lymphoma Kinase (PDB ID: 4ANL) was chosen as our receptor target. This receptor protein was finalized based on literature study. ALK tyrosine kinase receptor is a single polypeptide chain protein (Chain A) obtained from Homo sapiens with a sequence length of 342 amino acids, which harbors a single genetically induced mutation. In its secondary structure the ALK tyrosine kinase receptor, has 36% alpha helix (16 helices;126 residues) and 12 % beta sheets(12 strands; 42 residues).
Binding Site Identification
The site of interaction of the target protein, Anaplastic lymphoma kinase (4ANL) oncoprotein with the ligand was identified using SHARP. Potential protein-protein interaction sites on the receptor protein structures were predicted using SHARP software. Surfaced residue patches were defined and based on this a maximum of 6 parameters like Solvation potential, hydrophobicity; Accessible surface area, residue interface propensity, protrusion and Planarity are calculated. Using these parameters the site of interaction of proteins with each ligands were calculated 11 .
Docking studies
The selected compounds were docked against anaplastic lymphoma kinase protein (PDB ID:4ANL) using Molegro Virtual Docker (MVD). MVD employs MolDock scoring system (used in this study), which is based on guided differential evolution, a new hybrid search algorithm. The guided differential evolution algorithm combines the differential evolution optimization technique with a cavity prediction algorithm. The predicted cavities used during the search process, allows for a fast and accurate identification of potential binding poses 11 .
The intact protein structure, obtained from the protein data bank (PDB) was loaded on to MVD platform for docking process. Potential binding sites (also referred to as cavities or active sites) has been identified using the built-in cavity detection algorithm of MVD. The search algorithm is taken as Moldock SE and numbers of runs are taken 10 and max iterations were 2000 with population size 50 with an energy threshold of 100 12 . At each step least 'min' torsions/ translations/rotations were tested and the one giving lowest energy was chosen. After the docking simulation was over, the poses which were generated were sorted by rerank score.
T h e R e r a n k S c o r e u s e s a weighted combination of the terms used by the MolDock score mixed with a few addition terms (the Rerank Score includes the Steric (by LJ12-6) terms which are Lennard-Jones approximations to the steric energy -the MolDock score uses a piecewise linear potential to approximate the steric energy) 11 .
The ligand preparation module of MVD was used to manually prepare the chosen ligands. Bond order and hybridization assign wherever missing and flexible torsion and the ligands were deducted 13, 14, 15 . The target protein structures were prepared after careful removal of hetero atoms and water molecules and its electrostatic surface was generated. The docking was subjected towards the amino acid residues which were found to be part of interaction between HTSPs and VOPs.
The grid resolution was set at 0.3 A0.The maximum interaction was set at 1500 and maximum population size 50
RESULTS

Interaction site Prediction
The association of anaplastic lymphoma kinase (ALK) with anaplastic large cell lymphoma has been well characterized by various studies. There is a 60% association of anaplastic lymphoma kinase with the tumorogenesis process of anaplastic large cell lymphoma. It becomes quite imperative that their site of interaction be targeted in order to bring about a cure for Lymphoma. ALK has already been explored as a potential target for the treatment of Lymphoma 2 . The protein-ligand interaction between ALK and the selected compounds present in Vitex Negundo was analyzed and the precise site of interaction was identified by employing SHARP2. The amino acid residues of oncoproteins ALK that was interacting with the selected ligands were mapped out accurately.
Docking results
The natural compounds listed from the thorough literature survey were docked against mutant Anaplastic lymphoma kinase (4ANL ) at the specific sites of interaction, as predicted from SHARP2 results. For each compound, out of the many docking poses, only those which possess the highest moldock score and relatively good Hydrogen bond interaction was chosen.
The best few compounds which exhibited very good affinity towards the interaction site of the selected receptor protein 4ANL were picked out and the best ligand binding pose were selected on the basis of the aforementioned criteria. The docking results were tabulated for compounds that exhibited negative binding energy when docked against the binding site of mutant ALK tyrosine kinase receptor.
Out of the 16 compounds, that were screened only 4 compounds showed favourable binding affinity with the receptor, the others had no binding at all with the receptor.
62 -p-hydroxybenzoyl mussaenosidic acid was found to possess the best binding affinity 
DISCUSSION
Medicinal plants possess many bioactive phytocompounds, which are responsible for their specific medicinal properties. These phytochemicals can be identified with the help of numerous chromatographic separation techniques. The phytochemicals present in Vitex negundo were thoroughly identified by various chromatographic techniques and were documented in previous studies. Through a thorough electronic literature search of the Pubmed database, the phytochemicals present in Vitex negundo was identified and short listed. These selected compounds were then further shortlisted for their anticancer tendencies using PASS server.
In the Vitex negundo phytochemicals were docked against mutated anaplastic lymphoma kinase enzyme (PDB ID: 4ANL). Anaplastic lymphoma kinase is a receptor tyrosine kinase that belongs to the lymphocyte tyrosine kinase family. It is a monomer.
The primary step was to enumerate the amino acid residues involved at the site of interaction. A comprehensive list of all the amino acid residues which would be a part of the vital part of the interaction with the ligand was obtained through SHARP2 analysis.
Our study results showed that amino acids residues ARG1120, ASP1203,GLY1202, GLU1210 and SER1206 of mutant anaplastic lymphoma kinase were involved in the binding of 62 -p-hydroxybenzoyl mussaenosidic acid with the highest binding score of -127.723. p-hydroxybenzoyl mussaenosidic acid was identified and characterized from the ethanolic extracts of the leaf of Vitex negundo plant. P-hydroxybenzoyl mussaenosidic acid from vitex negundo plant has a proven hepatoprotective activity. N.Tiwari et al (2013) has demonstrated ant tubercular effect of p-hydroxybenzoyl mussaenosidic acid 17, 18 . Betulinic acid had the next highest binding energy of -95.598 with the mutated anaplastic lymphoma kinase receptor. GLY1269, ASP1270, LEU1122 are the amino acids of the receptor proteins mediating this interaction. Betulinic acid a pentacyclic terpenoid was identified from Vitex negundo leaves. Apart from vitex negundo Betulinic acid is present in various other plants as well. Our results were consistent with the findings of Kumar et al, who established the anticancer activity of Betulinic acid from Dillenia indica L. 19, 20 . Following Betulinic acid it was the phytocompound Viridiflorol that demonstrated good moldock score with our target protein.
Viridiflorol interacts with the aminoacid anaplastic lymphoma kinase through the amino acid MET1199. Viridiflorol is a phytochemical present in the oil extracted from Vitex negundo leaves. Viridiferol is an essential oil which is present in other plants apart from Vitex negendo. Lucas et al demonstrated the antioxidant activity, antiinflammatory and antituberculous activity of Viridiflorol from Allophylus edulis plant 21, 22 . Protocatechuic acid exhibited a binding score of -63.0854 when docked against our target receptor 4ANL. Protocatechuic acid is present in the seeds of the vitex negundo plant. Protocatechuic acid interacts with the target receptor mutant ALK through the following amino acids ASP1160, ASP1163, GLU1167, THR1151, LEU1152, PHE1164 23 . Protocatechuic acid is widely distributed in many plants and natural products like green tea and honey. Cytotoxicity, apoptosis and antigenotoxicity od Protocatechuic acid was demonstrated by Anter et al 24 .
CONCLUSION
Anaplastic lymphoma kinase is an important tyrosine kinase receptor. The mutant form of anaplastic lymphoma kinase is involved in pathogenesis of various tumors like neuroblastoma, anaplastic large cell lymphoma etc. Thus, making this enzyme an attractive target for various therapeutic interventions. Among the 16 selected phytocompounds screened from Vitex negundo extracts in this study, only four compounds have emerged as promising candidates for their anticancer potential, evaluated by their binding affinity towards their target protein. The docking results revealed that p-hydroxybenzoyl mussaenosidic acid exhibit the highest binding affinity towards the site of interaction. Thus our study indicates that p-hydroxybenzoyl mussaenosidic acid as a potential candidate against the mutant anaplastic lymphoma kinase enzyme that induces tumors such as neuroblastoma and anaplastic large cell lymphoma. Further in-vitro and in-vivo analysis is needed to follow up and substantiate the anti-cancer activities of these compounds.
Limitations of the study
Only selected compounds were shortlisted and screened for their anti cancer activity against mutated anaplastic lymphoma kinase protein. Lack of validation of the results with in-vitro and in-vivo studies.
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